Abstract:The structural transition of prion proteins from a native alpha-helix (PrPC) to a misfolded beta-sheet-rich conformation (PrPSc) is believed to be the main cause of a number of prion diseases in humans and animals. Understanding the molecular basis of misfolding and aggregation of prion proteins will be valuable for unveiling the etiology of prion diseases. However, due to the limitation of conventional experimental techniques and the heterogeneous property of oligomers, little is known about the molecular architecture of misfolded PrPSc and the mechanism of structural transition from PrPC to PrPSc. The prion fragment 127-147 (PrP127-147) has been reported to be a critical region for PrPSc formation in Gerstmann-Straussler-Scheinker (GSS) syndrome and thus has been used as a model for the study of prion aggregation. In the present study, we employ molecular dynamics (MD) simulation techniques to study the conformational change of this fragment that could be relevant to the PrPC-PrPSc transition. Employing extensive replica exchange molecular dynamics (REMD) and conventional MD simulations, we sample a huge number of conformations of PrP127-147. Using the Markov state model (MSM), we identify the metastable conformational states of this fragment and the kinetic network of transitions between the states. The resulting MSM reveals that disordered random-coiled conformations are the dominant structures. A key metastable folded state with typical extended beta-sheet structures is identified with Pro137 being located in a turn region, consistent with a previous experimental report. Conformational analysis reveals that intrapeptide hydrophobic interaction and two key residue interactions, including Arg136-His140 and Pro137-His140, contribute a lot to the formation of ordered extended beta-sheet states. However, network pathway analysis from the most populated disordered state indicates that the formation of extended beta-sheet states is quite slow (at the millisecond level), as large structural rearrangement is needed from disordered states. We speculate that the formation process of the extended beta-sheet folded states may represent an important event during the early formation of prion oligomers and the results of our study provide insights into the molecular details of the early stage of prion aggregation.

Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Structural and Dynamic Properties of the Human Prion Protein.

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Structural and Dynamical Mechanisms of a Naturally Occurring Variant of the Human Prion Protein in Preventing Prion Conversion?

Manganese-induced Changes of the Biochemical Characteristics of the Recombinant Wild-Type and Mutant PrPs

Effects of the pathological E200K mutation on human prion protein: A computational screening and molecular dynamics approach

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

Different folding mechanisms in prion proteins from mammals with different disease susceptibility observed at the single-molecule level

Familial Cjd Associated Prp Mutants Within Transmembrane Region Induced Ctm-Prp Retention In Er And Triggered Apoptosis By Er Stress In Sh-Sy5y Cells

Met/Val129 polymorphism of the full-length human prion protein dictates distinct pathways of amyloid formation

Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents

The Folding Mechanism And Key Metastable State Identification Of The Prp127-147 Monomer Studied By Molecular Dynamics Simulations And Markov State Model Analysis

Structural and dynamical determinants of a β-sheet-enriched intermediate involved in amyloid fibrillar assembly of human prion protein

Loss of Residues 119-136, Including the First β-strand of Human Prion Protein, Generates an Aggregation-competent Partially "Open" Form

Molecular dynamics and optimization studies of horse prion protein wild type and its S167D mutant

Folding Pathways of Prion and Doppel

Post-translational modifications in prion diseases

A Transient Intermediate Populated in Prion Folding Leads to Domain Swapping

Prions Mediated Neurodegenerative Disorders.